Fabrication and characterization of an inorganic gold and silica nanoparticle mediated drug delivery system for nitric oxide

Nitric oxide (NO) plays an important role in inhibiting the development of hepatic fibrosis and its ensuing complication of portal hypertension by inhibiting human hepatic stellate cell (HSC) activation. Here we have developed a gold nanoparticle and silica nanoparticle mediated drug delivery system containing NO donors, which could be used for potential therapeutic application in chronic liver disease. The gold nanoconjugates were characterized using several physico-chemical techniques such as UV-visible spectroscopy and transmission electron microscopy. Silica nanoconjugates were synthesized and characterized as reported previously. NO released from gold and silica nanoconjugates was quantified under physiological conditions (pH = 7.4 at 37 degrees C) for a substantial period of time. HSC proliferation and the vascular tube formation ability, manifestations of their activation, were significantly attenuated by the NO released from these nanoconjugates. This study indicates that gold and silica nanoparticle mediated drug delivery systems for introducing NO could be used as a strategy for the treatment of hepatic fibrosis or chronic liver diseases, by limiting HSC activation.

[1]  S. Friedman,et al.  Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts. , 2005, The American journal of pathology.

[2]  Chitta Ranjan Patra,et al.  Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells , 2007 .

[3]  James H Thrall,et al.  Nanotechnology and medicine. , 2004, Radiology.

[4]  Hong Wang,et al.  Peroxynitrite-Induced Neuronal Apoptosis Is Mediated by Intracellular Zinc Release and 12-Lipoxygenase Activation , 2004, The Journal of Neuroscience.

[5]  Michael A. Wilson,et al.  Nanotechnology: Basic Science and Emerging Technologies , 2002 .

[6]  Rasmus Niemi,et al.  Targeting of porous hybrid silica nanoparticles to cancer cells. , 2009, ACS nano.

[7]  McDowell Em,et al.  Histologic fixatives suitable for diagnostic light and electron microscopy. , 1976 .

[8]  J. González‐Gallego,et al.  S-nitroso-N-acetylcysteine attenuates liver fibrosis in cirrhotic rats , 2010, Journal of Molecular Medicine.

[9]  P. Mulvaney.  Nanotechnology—Basic Science and Applicationsby K. Kannangara, B. Raguse, M. Simmons, G. Smith and M. Wilson , 2002 .

[10]  Alaaldin M. Alkilany,et al.  Gold nanoparticles in biology: beyond toxicity to cellular imaging. , 2008, Accounts of chemical research.

[11]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[12]  P. Alivisatos.  The use of nanocrystals in biological detection , 2004, Nature Biotechnology.

[13]  C. Barbé,et al.  Silica Particles: A Novel Drug‐Delivery System , 2004 .

[14]  V. Shah,et al.  Inhibition of GTP-dependent vesicle trafficking impairs internalization of plasmalemmal eNOS and cellular nitric oxide production , 2003, Journal of Cell Science.

[15]  Ludovic Jullien,et al.  Synthesis and properties of water-soluble gold colloids covalently derivatized with neutral polymer monolayers. , 2002, Journal of the American Chemical Society.

[16]  K. Iwaisako,et al.  Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis. , 2008, Gastroenterology.

[17]  J. Sitzmann,et al.  Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[18]  Amitava Das,et al.  Nitric oxide promotes caspase‐independent hepatic stellate cell apoptosis through the generation of reactive oxygen species , 2008, Hepatology.

[19]  D. Mukhopadhyay,et al.  Nitric oxide promotes endothelial cell survival signaling through S-nitrosylation and activation of dynamin-2 , 2007, Journal of Cell Science.

[20]  Igor L. Medintz,et al.  Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.

[21]  Thomas J Webster,et al.  Nanomedicine: what’s in a definition? , 2006, International journal of nanomedicine.

[22]  J F Hainfeld,et al.  Gold nanoparticles: a new X-ray contrast agent. , 2006, The British journal of radiology.

[23]  D. Mukhopadhyay,et al.  Pro‐angiogenic Properties of Europium(III) Hydroxide Nanorods , 2008 .

[24]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.

[25]  Y. Leshem,et al.  The characterization and contrasting effects of the nitric oxide free radical in vegetative stress and senescence of Pisum sativum Linn. foliage , 1996 .

[26]  D. Mukhopadhyay,et al.  Inorganic phosphate nanorods are a novel fluorescent label in cell biology , 2006, Journal of nanobiotechnology.

[27]  D. Rockey,et al.  Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. , 1998, Gastroenterology.

[28]  Chitta Ranjan Patra,et al.  Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. , 2010, Advanced drug delivery reviews.

[29]  Amitava Das,et al.  FXR Promotes Endothelial Cell Motility Through Coordinated Regulation of FAK and MMP-9 , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[30]  R. Groszmann,et al.  Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[31]  D. Mukhopadhyay,et al.  Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. , 2008, Cancer research.

[32]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[33]  A. Spurr.  A low-viscosity epoxy resin embedding medium for electron microscopy. , 1969, Journal of ultrastructure research.

[34]  V. Shah,et al.  Intracellular fate of a targeted delivery system , 2008 .

[35]  V. Shah,et al.  Defects in cGMP-PKG pathway contribute to impaired NO-dependent responses in hepatic stellate cells upon activation. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[36]  Vincent M Rotello,et al.  Gold nanoparticle-mediated transfection of mammalian cells. , 2002, Bioconjugate chemistry.

[37]  Amitava Das,et al.  Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function. , 2008, Gastroenterology.

[38]  D. Balding,et al.  HLA Sequence Polymorphism and the Origin of Humans , 2006 .

[39]  M. Meyerhoff,et al.  Synthesis, characterization, and controlled nitric oxide release from S-nitrosothiol-derivatized fumed silica polymer filler particles. , 2005, Journal of biomedical materials research. Part A.

[40]  D. Astruc,et al.  Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. , 2004, Chemical reviews.

[41]  Kemin Wang,et al.  Imaging breast cancer cells and tissues using peptide-labeled fluorescent silica nanoparticles. , 2008, Journal of nanoscience and nanotechnology.

[42]  D. Mukhopadhyay,et al.  In vivo toxicity studies of europium hydroxide nanorods in mice. , 2009, Toxicology and applied pharmacology.